The US arm of drug firm LupinNSE 0.97 % is recalling 6,752 bottles of Testosterone Topical solution from the American market on account of defective container, the USFDA said. The product is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone. Lupin Pharmaceuticals Inc is recalling the 6,752 bottles of Testosterone Topical solution in the strength of 30mg/1.5mL manufactured by Lupin at its Pithampur plant, ?..